Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications.
about
Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomographyImaging markers for Alzheimer disease: which vs howEarly-onset Alzheimer's disease versus frontotemporal dementia: resolution with genetic diagnoses?Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study.How Does the Patient Benefit from Clinical PET?Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.Amyloid imaging for dementia in CanadaPartial volume correction using structural-functional synergistic resolution recovery: comparison with geometric transfer matrix method.Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationThe cingulate island sign within early Alzheimer's disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer's disease from dementia with Lewy bodiesPractical utility of amyloid and FDG-PET in an academic dementia center.Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.Analytical aspects of molecular Alzheimer's disease biomarkers.Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.Clinical workout for the early detection of cognitive decline and dementia.Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.Corticobasal syndrome: A diagnostic conundrum.Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia.Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer's disease - the case of florbetapir.APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction.
P2860
Q21146623-3363CBDB-1A91-426E-98BC-3850F73076BFQ27001254-F7459E88-C183-424E-B46C-C8D3DC820832Q30703922-1D311319-490C-418B-9FB1-A51236277F58Q34426744-AC4D8EC0-A6CE-4B07-8977-EC91567C2785Q35988082-0FA84745-5BEE-4321-961E-560E931A3896Q36103515-A1F98570-6301-4A95-AA00-661D036775C2Q36526176-75265D8F-CBD4-4007-9A43-E5DD08557BC3Q36632979-A98CD7E3-7BEE-46BB-903D-C0CC0D82D50CQ36905398-A63DD893-280E-4189-808F-46F2BF276FA2Q36914587-613A51B7-851D-4C20-A6E0-E1A17D606252Q37069527-1003E6A1-7436-41DA-86DD-483296FF3F8BQ37250257-523F7FE7-84DB-4476-B382-FFCC36EDAAB4Q37518041-B8733D3B-75F8-4BE7-9EC1-1C24D245F2D7Q37693470-EDB912E9-09B9-47CC-8CA9-D8BE8C7DB03AQ37703254-2C8B5417-0E2B-410E-A778-B7C9190A371DQ38037149-2406C680-3D34-40C4-A7E0-6B54260ADFD3Q38219529-A2202FF2-CBBE-4B0C-9920-81E4CE11B774Q38255755-0DBBAF4A-CFBF-4EF8-A690-BDDEC726D165Q38600277-FEBB9F7A-8FAC-479A-B998-7C62E9261BD3Q38903262-42DD3002-23C7-44B4-9791-891194BCAD59Q46016190-5EEAEDAD-3273-4C23-AAAD-6BBFDF0D1F4CQ46427093-7B9DE7BC-98FB-4980-A9B8-6F7BFE2F6B59Q46678949-54A38F16-500B-48A0-B61F-2FBBBC9DCD9EQ47975620-CBB8D96D-4B56-432C-9231-308207D22984Q50981551-1CBE1DC1-A38A-4757-B2FF-013B20A15180Q55373234-B8DB37F1-C4C8-43DD-94C6-9CEFF0D8F7B3
P2860
Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Amyloid imaging in the differe ...... tential clinical applications.
@ast
Amyloid imaging in the differe ...... tential clinical applications.
@en
type
label
Amyloid imaging in the differe ...... tential clinical applications.
@ast
Amyloid imaging in the differe ...... tential clinical applications.
@en
prefLabel
Amyloid imaging in the differe ...... tential clinical applications.
@ast
Amyloid imaging in the differe ...... tential clinical applications.
@en
P2860
P356
P1476
Amyloid imaging in the differe ...... tential clinical applications.
@en
P2093
Robert Laforce
P2860
P2888
P356
10.1186/ALZRT93
P407
P577
2011-11-10T00:00:00Z
P5875
P6179
1027865371